[Retracted] Effect of CMB Carrying PTX and CRISPR/Cas9 on Endometrial Cancer Naked Mouse Model

Figure 2

CCK-8 assay analysis of the relative cell viability in the naked mouse tail intravenous CMB, CMB-CRISPR/Cas9, CMB-PTX, CMB-PTX-CRISPR/Cas9, and PTX. P < 0.01, P < 0.001 vs. control group, P < 0.05, and P < 0.01, and P < 0.001 vs. CMB-PTX-CRISPR/Cas9 group.